Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 22, 2017 – Bausch and Lomb announced the FDA approval of Lumify (brimonidine) 0.025% ophthalmic solution, to relieve redness of the eye due to minor eye irritations.
Download PDF
Return to publications
